HOME >> MEDICINE >> NEWS
Penn researchers announce results of Phase I trial using combretastatin drug

(Philadelphia, PA) -- New approaches are needed to treat solid malignant tumors that cannot be removed surgically and are resistant to traditional powerful chemotherapy drugs. In a Phase I clinical trial, a team of researchers at the University of Pennsylvania Cancer Center has found that patients with solid cancerous tumors were able to safely tolerate a new drug, originally derived from a South African willow bush, that interacts with the tumor's blood supply. James P. Stevenson, MD, assistant professor of medicine at Penn and lead author of the study, will present these findings at the 91st American Association of Cancer Research Meeting on Tuesday, April 4, 2000 in San Francisco.

Combretastatin A4 phosphate is a drug that is classified as a vascular targeting agent. It selectively targets and reduces or destroys blood vessels supplying malignant tumors while sparing the vasculature of normal tissues. Vascular targeting agents like combretastatin attack proliferating blood vessels that already exist, whereas angiogenesis inhibitors generally stop new blood vessels from developing.

In this study, 29 patients with a range of solid tumors, unresponsive to traditional chemotherapy, were treated with a daily intervenous dose of combretastatin for five consecutive days every three weeks. All of the patients were given CT scans before and at the end of the treatment cycle to determine changes in tumor blood supply. Nine patients who were given the highest dose of combretastatin were monitored via MRI. Dr. Stevenson's team found evidence of a decrease in blood flow to the tumor following combretastatin therapy in five of the nine patients who were followed by MRI.

"These early results are promising and suggest that combretastatin may affect tumor blood supply," says Stevenson. "We will continue investigating this drug for its potential benefits in fighting advanced cancers."

T
'"/>

Contact: Sue Montgomery
sue.montgomery@uphs.upenn.edu
215-349-5657
University of Pennsylvania School of Medicine
3-Apr-2000


Page: 1 2

Related medicine news :

1. Indiana University researchers closer to helping hearing-impaired using stem cells
2. Protein that helps skin cancer spread identified by Stanford researchers
3. US life expectancy about to decline, researchers say
4. Gene for age-related macular degeneration discovered by Yale researchers
5. Dartmouth researchers find where musical memories are stored in the brain
6. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
7. US cancer researchers launch first American-Israeli cancer conference
8. USC dental researchers develop first test for predicting cavities in children
9. Young blood revives aging muscles, Stanford researchers find
10. Uric acid may help reduce effects of spinal cord injury, Jefferson researchers find
11. Age should not be a factor in determining heart transplantation eligibility, researchers say

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... , ... Temprian, a spinoff from Northwestern University, has a ... is vitiligo. Vitiligo patients develop progressive depigmentation of the skin. There is no ... prevalent in all ethnic groups, it is most visible and impactful in people ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... Safety Professional of the Year Award to Eric Simmons of Temecula, California. ... 250 nominations. Simmons, who holds a master’s degree in occupational safety and health ...
(Date:7/2/2020)... Conn. (PRWEB) , ... July 02, 2020 , ... ... of many businesses, including dental offices for non-emergency work. In conjunction with the ... reopening guidelines for Connecticut dental practices in mid-May. , Due to safety ...
(Date:7/1/2020)... ... July 01, 2020 , ... ABSTRAX, an industry leader ... its new terpene infused product line including custom rolling papers, cones, flat ... terpene profiles and flavors worldwide. , “We’ve made it easier than ever for ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... MD, Associate Professor of Medicine at the University of Massachusetts Medical School- Baystate ... LLC have joined the SIDM Board of Directors. Dr. Salvador and Ms. Gaffey’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2020)... (PRWEB) , ... June 24, 2020 , ... The R3 ... Diego and Nashville. The two day courses offer providers a hands on approach to ... offered as a Virtual Live Stream for providers who wish to enroll remotely. , ...
(Date:6/24/2020)... , ... June 24, 2020 , ... ... a number of common questions on County Line Chiropractic’s YouTube channel. ... questions. , County Line Chiropractic has six locations in the South Florida area, ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... of its refreshed brand and new website, which can be found at: ... federal and state agencies comprehensive, cutting-edge solutions — and this rebrand reflects HMS’ ...
Breaking Medicine Technology:
Cached News: